-transparent.png){kind=logo}
Submaximal exercise heart rate was measured after oral administration of placebo, tertatolol 5 mg, propranolol 80 mg, and atenolol 100 mg to 12 subjects in a double-blind cross-over study. The peaks of beta-blocking activity, observed at 2 hr, were of similar extent for the 3 drugs. The duration of activity of tertatolol, a beta blocker with a short elimination half-life, extended up to 24 hr as did that of atenolol, but was longer than that of propranolol which reached only 18 hr. These results support once-daily administration of tertatolol in therapy.
Related Publications
P Desche, and
A Cournot, and
O Guery, and
J F Prost, and
J Duchier
November 1989,
American journal of hypertension,
P Desche, and
A Cournot, and
O Guery, and
J F Prost, and
J Duchier
January 1989,
Archives internationales de pharmacodynamie et de therapie,
P Desche, and
A Cournot, and
O Guery, and
J F Prost, and
J Duchier
May 1990,
Canadian journal of anaesthesia = Journal canadien d'anesthesie,
P Desche, and
A Cournot, and
O Guery, and
J F Prost, and
J Duchier
April 1985,
The American journal of cardiology,
P Desche, and
A Cournot, and
O Guery, and
J F Prost, and
J Duchier
May 1979,
European journal of pharmacology,
P Desche, and
A Cournot, and
O Guery, and
J F Prost, and
J Duchier
February 1985,
Annals of emergency medicine,
P Desche, and
A Cournot, and
O Guery, and
J F Prost, and
J Duchier
October 1988,
Circulation,
P Desche, and
A Cournot, and
O Guery, and
J F Prost, and
J Duchier
September 1971,
The Journal of allergy and clinical immunology,
P Desche, and
A Cournot, and
O Guery, and
J F Prost, and
J Duchier
December 1975,
Clinical pharmacology and therapeutics,
P Desche, and
A Cournot, and
O Guery, and
J F Prost, and
J Duchier
September 1976,
European journal of clinical pharmacology,
